KR20250111134A - 폴리펩티드 억제제, 이의 제조 방법 및 응용 - Google Patents

폴리펩티드 억제제, 이의 제조 방법 및 응용

Info

Publication number
KR20250111134A
KR20250111134A KR1020257019116A KR20257019116A KR20250111134A KR 20250111134 A KR20250111134 A KR 20250111134A KR 1020257019116 A KR1020257019116 A KR 1020257019116A KR 20257019116 A KR20257019116 A KR 20257019116A KR 20250111134 A KR20250111134 A KR 20250111134A
Authority
KR
South Korea
Prior art keywords
amino acids
alkyl
integers
compound
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020257019116A
Other languages
English (en)
Korean (ko)
Inventor
지아치앙 동
원셩 위
윈 천
바오 청
전 공
Original Assignee
상하이 한서 바이오메디컬 컴퍼니 리미티드
장쑤 한서 파마슈티칼 그룹 캄파니 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 상하이 한서 바이오메디컬 컴퍼니 리미티드, 장쑤 한서 파마슈티칼 그룹 캄파니 리미티드 filed Critical 상하이 한서 바이오메디컬 컴퍼니 리미티드
Publication of KR20250111134A publication Critical patent/KR20250111134A/ko
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
KR1020257019116A 2022-11-30 2023-11-30 폴리펩티드 억제제, 이의 제조 방법 및 응용 Pending KR20250111134A (ko)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
CN202211530438.1 2022-11-30
CN202211530438 2022-11-30
CN202310206299.5 2023-03-03
CN202310206299 2023-03-03
CN202310261818.8 2023-03-15
CN202310261818 2023-03-15
CN202310349519.X 2023-03-31
CN202310349519 2023-03-31
CN202311144489.5 2023-09-05
CN202311144489 2023-09-05
PCT/CN2023/135637 WO2024114762A1 (zh) 2022-11-30 2023-11-30 一种多肽抑制剂、其制备方法和应用

Publications (1)

Publication Number Publication Date
KR20250111134A true KR20250111134A (ko) 2025-07-22

Family

ID=91323029

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020257019116A Pending KR20250111134A (ko) 2022-11-30 2023-11-30 폴리펩티드 억제제, 이의 제조 방법 및 응용

Country Status (10)

Country Link
US (1) US20260193294A1 (cg-RX-API-DMAC7.html)
EP (1) EP4628499A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025540765A (cg-RX-API-DMAC7.html)
KR (1) KR20250111134A (cg-RX-API-DMAC7.html)
CN (1) CN120202212A (cg-RX-API-DMAC7.html)
AU (1) AU2023404553A1 (cg-RX-API-DMAC7.html)
IL (1) IL321139A (cg-RX-API-DMAC7.html)
MX (1) MX2025006152A (cg-RX-API-DMAC7.html)
TW (1) TW202440611A (cg-RX-API-DMAC7.html)
WO (1) WO2024114762A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025242221A1 (zh) * 2024-05-24 2025-11-27 上海翰森生物医药科技有限公司 新型修饰侧链、其制备方法和应用
WO2026013260A1 (en) 2024-07-12 2026-01-15 Zealand Pharma A/S Peptide inhibitors of interleukin-23 receptor
WO2026052109A1 (zh) * 2024-09-06 2026-03-12 上海翰森生物医药科技有限公司 一种多肽抑制剂的药物组合物及其用途
WO2026057052A1 (zh) * 2024-09-14 2026-03-19 深圳信立泰药业股份有限公司 一种il-23受体抑制剂及其制备方法和用途
WO2026138829A1 (zh) * 2024-12-23 2026-07-02 上海医药集团股份有限公司 多肽抑制剂及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201810154WA (en) * 2014-07-17 2018-12-28 Protagonist Therapeutics Inc Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
EP4021919A1 (en) 2019-08-30 2022-07-06 Merck Sharp & Dohme Corp. Pcsk9 antagonist compounds
US12577259B2 (en) 2019-12-20 2026-03-17 Merck Sharp & Dohme Llc PCSK9 antagonist compounds
MX2022008740A (es) * 2020-01-15 2022-09-23 Janssen Biotech Inc Peptidos inhibidores del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias.
SMT202500254T1 (it) * 2020-01-15 2025-09-12 Janssen Biotech Inc Inibitori peptidici del recettore dell'interleuchina-23 e loro uso per trattare malattie infiammatorie
AU2021383828A1 (en) * 2020-11-20 2023-07-06 Janssen Pharmaceutica Nv Compositions of peptide inhibitors of interleukin-23 receptor

Also Published As

Publication number Publication date
IL321139A (en) 2025-07-01
JP2025540765A (ja) 2025-12-16
MX2025006152A (es) 2025-07-01
CN120202212A (zh) 2025-06-24
US20260193294A1 (en) 2026-07-09
AU2023404553A1 (en) 2025-07-10
TW202440611A (zh) 2024-10-16
WO2024114762A1 (zh) 2024-06-06
EP4628499A1 (en) 2025-10-08

Similar Documents

Publication Publication Date Title
JP2025540765A (ja) ポリペプチド阻害剤、その製造方法及び応用
TW202118770A (zh) 異質雙環肽複合物
JP2514518B2 (ja) ヘプタペプチドおよびオクタペプチドのソマトスタチン類似アミド誘導体、それを含有する抗腫瘍剤
PT91927B (pt) Processo para a preparacao de novos inibidores de peptidase
US3817973A (en) Process for the preparation of cyclopeptides derived from polymyxins
JP7746628B1 (ja) Tnf受容体1活性を阻害するための環状ペプチド
CN105658670A (zh) 肽-低聚尿素嵌合化合物及其使用方法
ES2219066T3 (es) Derivados de 1,3-diaril-2-piridin-2-il-3-(piridin-2-ilamino)-propanol sustituidos, procedimiento para su preparacion, medicamentos que contienen estos compuestos y su utilizacion.
JPS63250360A (ja) サイモペンチンレトロ−インバーソ類似体及びそのフラグメント
JPH07508748A (ja) ヒト白血球エラスターゼに対する阻害剤としてのフッ素含有ジペプチド
CN120390747A (zh) 用于靶向递送应用的碳酸酐酶ix配体
JPS6026099B2 (ja) ペプチド、その酸附加塩およびその製造法
CN112851755B (zh) 一种线性脂肽化合物及其制备方法与应用
SCHULTZ et al. Synthesis and conformational properties of a synthetic cyclic peptide for the active site of α‐chymotrypsin
JPS5892642A (ja) 新規なペプチドおよびそれらの製造法
CA2061993A1 (en) Fucose-bearing cytostatics
JPS63264444A (ja) 親脂性アミノ酸誘導体及びその製法
JPH0356462A (ja) ピログルタミン酸誘導体
JPH0813835B2 (ja) ピログルタミン酸残基を有するトリペプチド誘導体
HK40105911A (en) Peptides comprising a phosphorylcholine conjugate and methods of synthesizing same
JPH02131458A (ja) 新スパガリン関連化合物、その製造法及びその用途
WO2002102833A1 (fr) Nouveaux derives d'endomorphine
JPH0338598A (ja) サイモペンチン類似体
EP4720087A1 (en) Peptide inhibitors of interleukin-23 receptor
AU2024280796A1 (en) Peptide inhibitors of interleukin-23 receptor

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

Q12 Application published

Free format text: ST27 STATUS EVENT CODE: A-1-1-Q10-Q12-NAP-PG1501 (AS PROVIDED BY THE NATIONAL OFFICE)